Be among the first 25 applicants

Get AI-powered advice on this job and more exclusive features.

Responsibilities

Develop and execute U.S. market access strategies to support product brands, therapeutic areas and future launches and ongoing commercialization.

Lead payer engagement strategy and execution, including national and regional commercial payers, PBMs, specialty pharmacy, Medicare and Medicaid.

Partner with strategic pricing and contracting, HEOR, government affairs, patient services and field access teams to develop compelling value propositions.

Oversee the development of access-related tools and resources including metrics and customer behavior.

Collaborate closely with the sales, marketing, medical affairs, and legal teams to ensure alignment on strategy and execution.

Monitor policy, reimbursement, and pricing landscape and assess implications for the business.

Support contracting strategy development and assist with negotiations as needed.

Manage relationships with external vendors, consultants and payer advisors.

Analyze access and utilization data to inform strategy and measure performance.

Actively serve as US market access SME/voice for the CSL business unit in the commercial organization.

Qualifications

Bachelors, preferably in life sciences or economics

MBA or MPH, preferred

Experience

Minimum 15+ years of progressive experience in US market access, managed markets, payer strategy or related pharmaceutical functions.

Deep understanding of U.S. healthcare system, reimbursement mechanisms, and payer landscape.

Deep understanding of health policy & health system environment for transformative and rare therapies.

Superior problem-solving skills, including demonstrated capability of applying previous experience to complex policy issues.

Excellent communication, collaboration, influence, strategic and analytical skills are required.

Ability to lead cross-functional teams in a fast-paced, dynamic environment.

US launch experience in specialty rare therapeutics (rare disease, immunology, hemophilia) – Preferred

Experience with Medicare Part B/D, Medicaid and commercial payers – Preferred

Familiarity with ICER, QALY models, and evidence-based value frameworks – Preferred

Understanding of value-based contracting and innovative reimbursement models – Preferred

#J-18808-Ljbffr